Listed

Ocean Biomedical, Inc.: Form 10-K for the period ended Dec 31, 2022

Filed with the SEC on Mar 31, 2023 and accepted by EDGAR at Mar 31, 2023, 10:33 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Operating income12 months2022-01-01 to 2022-12-31−$2.5mus-gaap:OperatingIncomeLoss
Interest expense12 months2022-01-01 to 2022-12-31$691us-gaap:InterestExpense
Net income12 months2022-01-01 to 2022-12-31−$958.4kus-gaap:NetIncomeLoss
Operating cash flow12 months2022-01-01 to 2022-12-31−$747.3kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2022-12-31$328.3kus-gaap:Cash
Current assetsAt period end2022-12-31$468.0kus-gaap:AssetsCurrent
Total assetsAt period end2022-12-31$110.9mus-gaap:Assets
Current liabilitiesAt period end2022-12-31$3.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-12-31$6.6mus-gaap:Liabilities
Shareholders' equityAt period end2022-12-31−$6.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-23-010129. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.